Evidence map›Paper›PMID 34200500›Full record

ReviewCells2021

How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System.

Elma Sakinatus Sajidah, Keesiang Lim, Richard W Wong

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Structure-function mapping and mechanistic insights on the SARS CoV2 Nsp1.Protein science : a publication of the Protein Society · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. SARS-CoV-2 and the Nucleus.International journal of biological sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elma Sakinatus SajidahDivision of Nano Life Science in the Graduate School of Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.
Keesiang LimWPI-Nano Life Science Institute, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0001-9330-5783
Richard W WongDivision of Nano Life Science in the Graduate School of Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.
Kanazawa University · JP

Funding

Japan Society for the Promotion of Science 17H05874Japan Society for the Promotion of Science 17K08655Japan Society for the Promotion of Science 19K23841Japan Society for the Promotion of Science 20K16262
6 · The paper itself

Abstract

The host nucleocytoplasmic trafficking system is often hijacked by viruses to accomplish their replication and to suppress the host immune response. Viruses encode many factors that interact with the host nuclear transport receptors (NTRs) and the nucleoporins of the nuclear pore complex (NPC) to access the host nucleus. In this review, we discuss the viral factors and the host factors involved in the nuclear import and export of viral components. As nucleocytoplasmic shuttling is vital for the replication of many viruses, we also review several drugs that target the host nuclear transport machinery and discuss their feasibility for use in antiviral treatment.

Indexed as

Virus Physiological PhenomenaActive Transport, Cell NucleusCell NucleusCOVID-19Host-Pathogen InteractionsHumansNucleocytoplasmic Transport ProteinsSARS-CoV-2VirusesVirus InternalizationVirus ReplicationNucleocytoplasmic Transport Proteinsantiviral drugclinical trialDengue virusEbola virusEpstein-Barr virusexportinHepatitis B virusHS-AFMHuman Immunodeficiency virusHuman PapillomavirusimportinsInfluenza Anuclear transport inhibitornucleoporinsSARS-CoV-2viral nuclear exportviral nuclear import

Identifiers

PMID34200500
PMCPMC8230057
OpenAlexW3172681111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.